Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma
Yanbin Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), Ming‐Rong Wang(Capital University of Economics and Business), De‐Chen Lin(Cedars-Sinai Medical Center), Man‐Li Luo(Sun Yat-sen University), Xiaoli Du(Huazhong Agricultural University), Yan Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Yaling Han(Harbin Medical University), Yu Zhang(Wannan Medical College), Xiaochun Wang(Gansu Provincial Hospital), Qimin Zhan(Peking University), Xiaoming Shen(Sun Yat-sen University), Xin Xu(Fujian Medical University), Zi‐Qiang Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhi‐Zhou Shi(Kunming University of Science and Technology)
Cited by 112
Related Papers
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
|EBioMedicine|2019|252
Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
|Nature Communications|2018|241